ZARR

News and price dashboard

Swept 00:18
Sources
27, all reachable
Items
76684
Flagged
9601
Last swept
00:18

STOCKS

121

OPTIONS

25

COMING UP

US majors and your names' earnings, next 7 days

Full calendar

Everything else — unscored, browse only, never pushed

Brief

Feed shape today

This is the unfiltered general feed: 200 items, and the overwhelming majority are routine Investing.com 8-K notices, Form 4 insider filings, TradingView chart posts and Nasdaq option-activity screens with no substance behind them. Twenty were read in full, and of those, most are the same automated "stock hits 52-week high/low" template run twice across the UK and US editions of Investing.com, so the duplicate pairs are one story each, not two.

A cluster of 52-week lows

The biggest single theme in the read items is a run of new 52-week lows. T-Mobile hit $147.89, down 32% over the year and 34.5% off its $225.93 high, with the ticker line showing TMUS down 7.70%. The article gives no reason for the day's drop, but notes earnings due October 28 and a string of recent broker notes: Raymond James upgraded to Outperform arguing SpaceX competition fears are overdone, KeyBanc stayed Overweight on possible upside in average revenue per account despite slightly higher churn from pricing actions, StoneX reiterated Buy on AI implementation, and JPMorgan cut its target to $260 from $275 while keeping Overweight and trimming revenue estimates to line up with T-Mobile's $19.30bn wireless service revenue guidance. NewAmsterdam Pharma touched $19.55, down 44.92% on the year with the ticker showing NAMS off 8.67%, against a $2.35bn market cap; the piece cites EU approval of its obicetrapib/ezetimibe fixed-dose combination, Stifel holding Buy and a $50 target after the failure of Novartis's HORIZON trial, RBC cutting to $42 from $50 over the Phase III PREVAIL interim analysis at a 35-38% estimated probability of success, and CEO Michael Davidson buying 10,000 shares for $226,500. MGM Resorts hit $27.93 against a $51.59 high, shown down 4.97%, with earnings five days out; the context given is Macau gaming revenue projected by Jefferies to fall 6-10% in October, a $107m room renovation disrupting Borgata, and Mizuho cutting its target to $55 from $60 after People Inc. withdrew its bid for the shares it doesn't own. Two more lows are quieter: Huntington Bancshares' 4.500% Series H preferred at $14.90, down 18.73% over the year on a 7.51% yield and a 56-year dividend record, and Selective Insurance Group's SIGIP preferred at $14.74, down 16.42%, yielding 7.75% with 52 straight years of dividends. Neither article gives a specific cause beyond general rate and financial-sector pressure.

The two highs, and what's behind them

Going the other way, Amerant Bancorp hit a 52-week high of $30.65, up 77.42% over a year and 53.72% year to date on a $1.2bn market cap, after Q3 2026 diluted EPS of $0.65 against the $0.57 consensus, revenue of $108.8m versus $103.35m expected, net income of $25.7m and a 1.0% return on assets, its best on that measure since 2022. Safety Insurance Group set an all-time high at $104.16, up 56% over the year, and the reason is specific: the Hart-Scott-Rodino waiting period on its merger with MAPFRE U.S.A. has expired, clearing a condition for the deal announced on 23 July 2026, under which Splash Merger Sub merges into Safety and the company becomes a MAPFRE subsidiary.

Macy's dividend

The only other full-text item with real content is Macy's declaring a regular quarterly dividend of 19.15 cents per share, payable 4 January 2027 to holders of record on 15 December 2026.

Filings with nothing attached

Four full-text items turned out to be bare 8-K notices with no body text at all: Ionis Pharmaceuticals, Zevia, Unity Software and Visa, all dated 23 October. There is nothing in them to read beyond the fact that a filing exists.

What the headline-only remainder contains

The rest is headlines only, so take them as stated and nothing more. Earnings coverage runs through regional banks and REITs: Preferred Bank beat on Q3 EPS with shares slipping premarket, First Hawaiian missed as shares fell with NIM gains offset by credit costs, WSFS beat with wealth revenue up 30% and ROTCE at 20.7%, and Kilroy Realty raised guidance on record leasing. On biotech, Roche's sefaxersen is reported to have shown a 43% proteinuria reduction in an IgA nephropathy trial, with Ionis named as partner, Vertex reported positive IgAN data with an FDA decision due 30 November, and the FDA approved a subcutaneous induction regimen for AbbVie's Skyrizi. Several analyst headlines sit unread: Jefferies raising Zymeworks on the Roche deal, Williams Trading cutting Deckers on weak DTC trends, RBC reiterating Outperform on Verisk, and Raymond James reiterating Strong Buy on Alnylam. On trade, two separate headlines say the US is expected to lift 50% tariffs on some Canadian agricultural and forestry goods, one framing it as relief for trade-dependent states. Commodities headlines point to cocoa falling on rising ICE inventories and higher Nigerian exports, coffee falling despite inventories at a five-week low, sugar supported by lower Brazilian production, and Indian crude imports up 16% in September. The remainder is chart-idea posts, option-activity screens, consensus-target adjustments and political social media, none of which carries anything beyond its own title.

20 read in full, 200 items in the section

Feed

155 stories · 155 newCross-publisher stories only
  1. Pinned
  2. 155 new
  3. PNC Financial Services completes $1.5 billion senior notes offering
    Investing.com - news 2 itemsalso Investing.com - UK
  4. Wynn Resorts subsidiary to invest up to MOP1.37 billion in Macau government fund
    Investing.com - news 2 itemsalso Investing.com - UK
  5. Picard Medical exchanges warrants for 200,000 shares of common stock
    Investing.com - UK 2 itemsalso Investing.com - news
  6. GBPAUD BEARISH BREAKOUT|SHORT|
    TradingView [COMMENT]
  7. WDC_ Low Risk High Reward Setup_Gap Filling
    TradingView [COMMENT]
  8. Acadia Pharmaceuticals announces retirement of R&D head, names interim consultant
    Investing.com - UK 2 itemsalso Investing.com - news
  9. Arc Group Securities Acquisition I receives Nasdaq notice on warrant listing
    Investing.com - UK 2 itemsalso Investing.com - news
  10. Graphano Energy amends private placement to add flow-through shares
    Investing.com - news 2 itemsalso Investing.com - UK
  11. Ardent Health reclassifies former CEO’s exit as termination for cause
    Investing.com - news 2 itemsalso Investing.com - UK
  12. Allegiant Travel exercises Boeing aircraft options and signs new executive contracts
    Investing.com - news 2 itemsalso Investing.com - UK
  13. Belpointe PREP receives early repayment on $5 million loan, terminates agreement
    Investing.com - news 2 itemsalso Investing.com - UK
  14. Bank of America issues Series WW preferred stock and related depositary shares
    Investing.com - news 2 itemsalso Investing.com - UK
  15. Expion Energy amends private placement terms, updates convertible debenture agreement
    Investing.com - news 2 itemsalso Investing.com - UK
  16. elliott waves
    TradingView [COMMENT]
  17. Caldwell sells IQTalent Partners to WinMil for $4.7 million
    Investing.com - news 2 itemsalso Investing.com - UK
  18. Medicus Pharma regains Nasdaq compliance with minimum bid price rule
    Investing.com - news 2 itemsalso Investing.com - UK
  19. ​Bitcoin 4H Advanced Market Structure Analysis
    TradingView [COMMENT]
  20. SPX500 Bullish Update!
    TradingView [COMMENT]
  21. Silver Bow Mining amends asset purchase agreement with Montana Goldfields
    Investing.com - news 2 itemsalso Investing.com - UK
  22. Vivid Seats Inc. Elects Chelsea Grayson to Board of Directors
    Nasdaq - stocks 2 publishers · 2 items
  23. elliott waves
    TradingView [COMMENT]
  24. 22nd Century Group raises $4.7 million through at-the-market stock sale
    Investing.com - news 2 itemsalso Investing.com - UK
  25. Edesa Biotech approves executive salary increases retroactive to July
    Investing.com - news 2 itemsalso Investing.com - UK
  26. Laser Photonics Corporation Receives Nasdaq Notice of Non-Compliance With $1.00 Minimum Bid Price Requirement
    Nasdaq - stocks 2 publishers · 5 itemsalso Investing.com - UK, Investing.com - news
  27. Andersons to eliminate chief human resources officer role as part of restructuring
    Investing.com - news 2 itemsalso Investing.com - UK
  28. CADCHF Bullish Breakout!
    TradingView [COMMENT]
  29. Greenwave Technology sets date for 2026 annual meeting and proposal deadlines
    Investing.com - news 2 itemsalso Investing.com - UK
  30. Image post from October 23, 2026
    Trump (Truth Social) 2 items
  31. SILVER - Big Cup and Handle
    TradingView [COMMENT]
  32. GBPCAD LOCAL SHORT|
    TradingView [COMMENT]
  33. GOLD - Bearish Double Top
    TradingView [COMMENT]
  34. GBP-USD Free Signal! Buy!
    TradingView [COMMENT]
  35. Canopy Growth shareholders approve board proposals at annual meeting
    Investing.com - news 2 itemsalso Investing.com - UK
  36. ETHUSDT Bullish Reversal Toward Resistance
    TradingView [COMMENT]
  37. Form 8K Canopy Growth Corporation For: 23 October
    Investing.com - UK 45 itemsalso Investing.com - UK
  38. Form 8K Proficient Auto Logistics Inc For: 23 October
    Investing.com - UK 3 itemsalso Investing.com - UK
  39. Form 8K Azio AI Holdings, Inc For: 23 October
    Investing.com - UK 5 itemsalso Investing.com - UK
  40. Form 8K 22nd Century Group Inc For: 23 October
    Investing.com - UK 9 items
  41. Form 4 Mastercraft Boat Holdings Inc For: 23 October
    Investing.com - UK 5 items
  42. Dollar Sees Support as T-note Yields Rise
    Nasdaq - stocks 2 items
  43. btc wtf (read the caption)
    TradingView [COMMENT]
  44. Colombia shares higher at close of trade; COLCAP up 0.46%
    Investing.com - UK 2 itemsalso Investing.com - news
  45. BTCUSD Bullish Reversal from Support
    TradingView [COMMENT]
  46. GridAI Technologies director Manpreet Uppal resigns from board
    Investing.com - news 2 itemsalso Investing.com - UK
  47. Form 8K Traws Pharma Inc For: 23 October
    Investing.com - UK 8 itemsalso Investing.com - UK
  48. Russia stocks higher at close of trade; MOEX Russia Index up 1.51%
    Investing.com - news 2 itemsalso Investing.com - UK
  49. Phathom Pharmaceuticals reports lawsuit over Voquezna exclusivity
    Investing.com - news 2 itemsalso Investing.com - UK
  50. Vital Farms pilots lower-priced free-range eggs at Target
    Investing.com - news 2 itemsalso Investing.com - UK
  51. Form 8K AppTech Payments Corp For: 23 October
    Investing.com - UK 4 itemsalso Investing.com - UK
  52. Form 8K Phathom Pharmaceuticals Inc For: 23 October
    Investing.com - UK 43 itemsalso Investing.com - UK
  53. The Largest Merger in History
    Brownstone Research [PROMO]
    SPCX+1.9%
  54. Brightline Interactive announces board resignation and new committee chairs
    Investing.com - news 2 itemsalso Investing.com - UK
  55. Why is Cumberland Pharmaceuticals stock sliding today?
    Investing.com - UK 109 items